Close Menu

USPTO

Title: RNA Sequence-specific Mediators of RNA Interference
Patent Number: 8,632,997
Filed: Oct. 4, 2010

Title: Detection of Small Nucleic Acids
Patent Number: 8,609,336
Filed: Feb. 7, 2012

Title: Methods for Diagnosing Breast Cancer Using microRNAs

Title: Assessing Left Ventricle Remodeling via Temporal Detection and Measurement of microRNA in Body Fluids
Patent Number: 8,592,151
Filed: Nov. 11, 2010

Title: Methods, Compositions, and Drug-delivery Systems for Intraocular Delivery of siRNA Molecules
Patent Number: 8,586,556
Filed: Dec. 21, 2009
Lead Inventor: Robert Lyons, Allergan

Title: Methods for Diagnosing Lung Cancer using microRNAs
Patent Number: 8,580,500
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

Title: Therapeutic Agent for Pulmonary Fibrosis
Patent Number: 8,574,623
Filed: Oct. 10, 2012
Lead Inventor: Yoshiro Niitsu, Nitto Denko

Title: Methods and Compositions Involving microRNA
Patent Number: 8,568,971
Filed: Sept. 24, 2010
Lead Inventor: David Brown, Asuragen

Title: RNAi Therapeutic for the Treatment of Hepatitis C Infection
Patent Number: 8,563,529
Filed: July 26, 2012
Inventor: Hengli Tang, Florida State University

Title: RNA Sequence-specific Mediators of RNA Interference
Patent Number: 8,552,171
Filed: Oct. 4, 2010
Lead Inventor: Thomas Tuschl, Max Planck Institute

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.